Profile
Boris Minev formerly worked at Genelux Corp., as Director-Immunotherapy &Translational Oncology from 2010 to 2015, UCSD Moores Cancer Center, as Director-Tumor Immunology & Immunotherap from 2000 to 2015, and Calidi Biotherapeutics, Inc., as Chief Medical Officer & President-Medical Affairs from 2015 to 2025.
Dr. Minev received his doctorate degree from Medical University Sofia.
Former positions of Boris Minev
| Companies | Position | End |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-07-28 |
| GENELUX CORPORATION | Corporate Officer/Principal | 2015-05-31 |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical research services for cancer treatment | Corporate Officer/Principal | 2015-05-31 |
Training of Boris Minev
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical research services for cancer treatment | Commercial Services |
Medical University Sofia
Medical University Sofia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
- Stock Market
- Insiders
- Boris Minev
















